NCT00834951CompletedPhase 2
A Prospective Multicenter Phase II Study of MabThera (Rituximab) Plus 2 Weekly CHOP Followed by Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- University of Aarhus
- Enrollment
- 40
Study Overview
Brief Summary
The purpose of this study is to determine whether the application of low dose total body irradiation following chemo-immuntherapy in elderly patients with aggressive with non-Hodgkin's lymphoma would be safe and potentially benecicial adjuvant therapy
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 60 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •previously untreated, pathology verified aggressive non-Hodgkin lymphoma of the diffuse large B-cell type according to the WHO classification. Age between 60 years and 80 years.Positive for an anti-CD20 antibody. Good performance status and normal initial normal blood count.
Exclusion Criteria
- •Patients with previous lymphoma associated with immune suppression of any sort. Diagnosis or history of indolent lymphoma or other malignancies. Marked impairment of any vital organ such as the heart, lung, liver or kidneys.
Investigators
Similar Trials
Completed
Phase 2
Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant ReconstructionsBreast CancerNCT02086578Memorial Sloan Kettering Cancer Center100
Completed
Phase 2
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell TransplantationMyelodysplastic SyndromesMyeloproliferative DisorderAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaT-cell LymphomaNon Hodgkin LymphomaB-cell LymphomaHodgkin LymphomaChronic Myelomonocytic LeukemiaNCT03734601Stanford University22
Terminated
Phase 2
Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHCIntrahepatic CholangiocarcinomaNCT02254681Allina Health System6
Recruiting
Not Applicable
The GOAL27-6 StudyHead and Neck CancerNCT05859828East and North Hertfordshire NHS Trust60
Unknown
Phase 2
Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver GeneLung AdenocarcinomaNCT03905317Sun Yat-sen University66